Certain autoantibodies exhibit promising diagnostic capabilities, and studies have indicated that serum autoantibodies targeting GAGE7, MAGEA1, CAGE, and p53 can aid in the diagnosis of lung cancer. Here, TP53 is linked to lung carcinoma.